Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Cultural Differences in Treatment Preferences and Perceptions of Acne (CDTPPA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03192163
Recruitment Status : Completed
First Posted : June 19, 2017
Last Update Posted : March 5, 2018
Sponsor:
Information provided by (Responsible Party):
Roopal Kundu, Northwestern University

Brief Summary:
This study will use a survey to examine relationships between culture, race, and ethnicity with treatment preferences and perceptions for acne vulgaris.

Condition or disease Intervention/treatment
Acne Vulgaris Other: Survey

Detailed Description:
The purpose of this study is to determine how explanatory models, perceptions, and treatment preferences of acne vulgaris vary across different cultures and racial and ethnic backgrounds. This study will also use Willingness to Pay to investigate differences in treatment valuation. Clarifying these differences will better inform patient counseling and treatment adherence by improving the quality of shared decision making.

Layout table for study information
Study Type : Observational
Actual Enrollment : 217 participants
Observational Model: Case-Only
Time Perspective: Cross-Sectional
Official Title: Cultural, Racial, and Ethnic Differences in Treatment Preferences and Perceptions of Acne Vulgaris
Actual Study Start Date : June 2015
Actual Primary Completion Date : February 2018
Actual Study Completion Date : February 2018

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Acne

Group/Cohort Intervention/treatment
ResearchMatch Group Other: Survey
31 question survey with questions regarding non-identifying demographic information such as age and gender. This survey also contains questions about acne treatment preferences, racial/ethnic background, and cultural identity in addition to a few Willingness to Pay questions.

Northwestern Center for Ethnic Skin Group Other: Survey
31 question survey with questions regarding non-identifying demographic information such as age and gender. This survey also contains questions about acne treatment preferences, racial/ethnic background, and cultural identity in addition to a few Willingness to Pay questions.




Primary Outcome Measures :
  1. Willingness to Pay [ Time Frame: 15 minutes ]
    percentage of income individual is willing to pay to use a treatment that improves his or her acne

  2. Preferred and Least Preferred Treatments [ Time Frame: 15 minutes ]
    ranked list of treatments for acne that individuals prefer and don't prefer using (ie. masks/facials, isotretinoin, etc) and reasons for why individuals prefer or don't prefer using that treatment (ie. cost, safety, efficacy, etc.)



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Adults with Acne vulgaris in the US
Criteria

Inclusion Criteria:

  • Subjects must have acne vulgaris, be at least 18 years of age, and must be able to complete a survey published in English.

Exclusion Criteria:

-


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03192163


Locations
Layout table for location information
United States, Illinois
Northwestern University Feinberg School of Medicine Department of Dermatology
Chicago, Illinois, United States, 60611
Sponsors and Collaborators
Northwestern University

Study Data/Documents: Survey  This link exits the ClinicalTrials.gov site
This is the RedCap survey that subjects will take.

Layout table for additonal information
Responsible Party: Roopal Kundu, Principal Investigator, Northwestern University
ClinicalTrials.gov Identifier: NCT03192163     History of Changes
Other Study ID Numbers: STU00205213
First Posted: June 19, 2017    Key Record Dates
Last Update Posted: March 5, 2018
Last Verified: March 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Additional relevant MeSH terms:
Layout table for MeSH terms
Acne Vulgaris
Acneiform Eruptions
Skin Diseases
Sebaceous Gland Diseases